A selection of invited lectures, session chairing and panel coordination by Professor Athanassios Vozikis at Greek and international scientific congresses, symposia and policy workshops. Select a year below to view the full record.
31
invited appearances
at scientific events
5
sessions chaired
or coordinated
2018–2026
span of the
documented record
Recurring themes
The talks concentrate on the economic evaluation of health technologies and on the translation of that evidence into reimbursement and public health policy.
Health Technology Assessment
Value-based assessment methodology, budget impact, cost-effectiveness thresholds and their role as barriers to funding innovation.
Immuno-oncology & innovative therapies
Assessment and reimbursement of immunotherapies, subcutaneous formulations and combination treatments in cancer care.
Pharmaceutical policy & expenditure
Pricing, negotiation and reimbursement mechanisms, orphan drugs, biosimilars and patient access to new treatments.
Public health & prevention
Return on investment in public health policies, tobacco harm reduction, differential taxation and health literacy.
Patient safety & risk management
Medical malpractice, risk management in health service provision and the economics of patient safety.
Health system reform
Continuity of care in the national health system, post-Covid restructuring of hospital services and the economics of the pandemic.
2–4 February 2026 · Athens
10th Annual Conference of the Hellenic Cancer Federation (ELLOK)
Invited speaker
“Shaping the patient care pathway — Investing in efficiency, evaluating care”
9 February 2026 · Athens
3rd Stakeholder Workshop on Situation Analysis of Health Technology Assessment (HTA) in Greece
Member of the expert group
9–11 December 2025 · Athens
Panhellenic Conference on Health Economics and Policy
Invited speaker
“Understanding the new HTA methodology: value-based assessment of medicines”
9–11 December 2025 · Athens
Panhellenic Conference on Health Economics and Policy
Invited moderator and discussant
Round table: “Public funding of oral health care as a foundation of general health in contemporary health systems”
29–30 September 2021 · Hybrid
4th Scientific Summit on Tobacco Harm Reduction: Novel Products, Research & Policy
Chair and moderator
Panel: “Is differential taxation a means to promote public health strategies?”
26 September 2021 · Hybrid
6th Scientific Forum “Oncology Quo Vadis: A Breath of Optimism”
Invited speaker
“Investment in public health policies and gains for the health system”
Session: “Prevention and palliative care — why do we forget them?”
22 September 2021 · Online
6th Conference “Hospital, Pharmaceuticals and Medical Technology: New Data and Challenges in the Post-Covid-19 Era”
Invited speaker
“Integration of health services and continuity of care in the National Health System”
Session 2: Redesigning hospital and post-hospital health services
21 September 2021 · Hybrid
1st Annual Conference “Risk Management — Going Forward”
Invited speaker
“Risk management in health services provision and patient safety: the case of medical malpractice”
Panel II: Risk management in the healthcare industry
23 March 2021 · Online
2021 HTA Conference “The Role of HTA in the Era of Radical Changes & Disruptive Innovation”
Invited speaker
“Budget impact and thresholds as barriers for funding innovation”
Session 3: Funding and financing models for new innovative treatments. Professor Michael Drummond (University of York) also contributed to this session.
16 December 2020 · Online
All.Can Greece workshop “Towards optimal cancer care”
Invited speaker
“All.Can: the next steps, starting from patients — studies and proposals”
7–10 December 2020 · Athens
Panhellenic Conference on Health Economics and Policy
Vice-Chair of the Scientific Committee
- Lecture: “The contribution of health economics to the efficient management of Covid-19” — session on the economic dimensions of the pandemic
- Chair and moderator of the session “Orphan drugs: who pays for innovation?”
- Chair and moderator of the session “Covid-19: would it be an equally threatening virus if our population had lower rates of diabetes and obesity?”
14–15 November 2020 · Online
Conference “Strength in Unity: Combined Treatment of Cancer”
Invited speaker
“How the cost of innovative oncology medicines is assessed in reimbursement decisions: the case of immuno-oncology”
23–25 October 2020 · Athens
Panhellenic Conference “On the Road to the Optimal Therapeutic Index in Oncology”
Invited speaker
“Assessment and reimbursement of innovative immunotherapies in oncology”
23 October 2020 · Online
Scientific event “The Present and Future of Treating the Oncology Patient with Subcutaneous Formulations”
Invited speaker
“The benefits of subcutaneous formulations for the health system”
16 October 2020 · Larissa
2nd Oncology Conference of Central Greece
Invited speaker
“Assessment and reimbursement of immunotherapy in cancer care”
25–27 September 2020 · Mani
5th Scientific Forum in Oncology “Quo Vadis?”
Invited speaker
“ROI (Return on Investment) for public health policies”
3–4 July 2020 · Grand Hyatt, Athens
11th Piraeus Oncology Conference “Multidisciplinary Management of Cancer”
Invited speaker
9 June 2020 · Athens
3rd Forum “The Future of Health — The Future of Medicines”
Invited speaker
18 February 2020 · Divani Caravel, Athens
5th HTA Conference “Value Driven Healthcare and Shared Decision Making”
Invited speaker
31 January – 2 February 2020 · Athens
4th Annual Conference of the Hellenic Cancer Federation (ELLOK)
Chair and moderator of the second session
“HTA Seminar — Health Technology Assessment: how is the value of anticancer therapies estimated?”
25–26 January 2020 · Lake Plastira
Two-day conference “A New Era in the Treatment of Cancer”
Invited speaker
“Pharmaceutical expenditure, assessment and negotiation: how much and in what way do they affect patient access to new innovative therapies?”
10–12 December 2019 · Athens
Panhellenic Conference on Health Economics and Policy
Invited speaker
“The ‘value’ of pharmaceutical care and the questions surrounding its assessment and reimbursement”
10–12 December 2019 · Athens
Panhellenic Conference on Health Economics and Policy
Invited speaker
“Problems and challenges of oncology care in Greece”
Session: All.Can Greece Dialogue Platform
27 November 2019 · Athens
BMS Hellas scientific event “The Challenge of Immunotherapy as the Optimal Choice in NSCLC”
Invited speaker
“The value of immunotherapy in the management of non-small cell lung cancer”
8–10 November 2019 · Tripoli
7th Symposium of Oncology Nursing
Invited speaker
“Benefits from the development of the All.Can Greece platform”
1–2 November 2019 · Athens
10th Piraeus Oncology Conference
Invited speaker
“Pharmacoeconomic challenges in the era of immuno-oncology”
31 October – 3 November 2019 · Athens
14th Panhellenic Conference of Surgical Oncology
Invited speaker
“The impact of health system inefficiency on oncology care in Greece”
24 September 2019 · Athens
Conference on Biosimilars: The Growing Role of Biologics and Biosimilars in Greece
Invited speaker
“Biosimilar landscape in Greece: a stakeholder mapping and analysis”
13–14 September 2019 · Athens
Debates on Cancer Treatments and Cost-Effectiveness: 6th Meeting
Invited speaker
“Assessment and management of pharmaceutical innovation: the case of immuno-oncology”
19 June 2019 · Athens
“ESY Against Cancer” event, organised by BMS Hellas
Invited speaker
“The assessment of pharmaceutical innovation: the case of immuno-oncology”
5–7 October 2018 · Mani
3rd Scientific Forum in Oncology “Quo Vadis?”
Invited speaker
“The Cost of Doing Nothing”